Regardless, activation of caspase-3 (Fig. 5C) and increased subdiploid staining (Fig. 5D) suggest that canertinib promotes apoptosis in ErbB2+Ph+ALL cells. This evidence concerns the gene CASP3 and acute lymphoblastic leukemia.